GLP1R and diabetes mellitus: A clinical study also evaluated the combination of IDeg with rapid-acting insulin aspart (IDegAsp) and the fixed-ratio formulation with the Glucagon-like peptide-1 (GLP-1) analog liraglutide (IDegLira), both of which offer further options for simplifying treatment regimens in diabetes management.